Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
≥25-≤50
General Information
Version
13
Revision date
2022-06-17
Product name
Composite Pinhole Filler 28C1
1.2.1 Relevant identified uses
Filling material for aeroplane body’s
1.2.2. Uses advised against
Reason
Emergency telephone
31 (0)71 308 6944
Icons in SDS
Company Information
company name
AkzoNobel Aerospace Coatings
e-mail address of the competent person responsible for the Safety Data Sheet
PSRA_SSH@akzonobel.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H226, H372
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
Flammable liquid and vapor. Causes damage to organs through prolonged or repeated exposure.
Prevention
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Do not breathe vapor.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
crystalline silica, respirable powder Solvent naphtha (petroleum), medium aliph.
Supplemental label elements
Warning! Do not use together with other products. May release dangerous gases (chlorine).
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 3, H226 STOT RE 1, H372 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
